Cladribine, sold under the brand name Leustatin, among others, is a medication used to treat hairy cell leukemia (formally named leukemic reticuloendotheliosis) and B-cell chronic lymphocytic leukemia.

Mar 1, 2025 · Cladribine belongs to the group of medicines called antimetabolites. It is used to treat hairy cell leukemia, a cancer of the blood and bone marrow. It is also sometimes used to treat other kinds of cancer, as determined by your doctor.

Sep 27, 2024 · Cladribine is used to treat relapsing multiple sclerosis (MS) in adults. cladribine will not cure MS, it will only decrease the frequency of relapse symptoms. Cladribine is usually given after other treatments have failed. Cladribine may also be used for purposes not listed in this medication guide.

Jan 29, 2025 · Cladribine Injection, USP (also commonly known as 2-chloro-2΄-deoxy- β -D-adenosine) is a synthetic antineoplastic agent for continuous intravenous infusion. It is a clear, colorless, sterile, preservative-free, isotonic solution.

This page contains brief information about cladribine and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Mar 20, 2023 · Cladribine (2-chlorodeoxyadenosine [2-CdA]) is a synthetic deoxyadenosine (purine) analog classified as an anti-metabolite and anti-pyrimidine agent. Drs. Beutler and Carson, 2 scientists working at the Scripps Institute, discovered and synthesized the compound during the 1980s.

Mar 1, 2025 · Cladribine is used to treat the relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive disease, in patients who have been previously treated with other medicines that did not work well.

Jul 18, 2023 · Cladribine is an anticancer (antineoplastic) and immunosuppressive medication used in the treatment of adults with hairy cell leukemia, a type of blood cancer, and relapsing forms of multiple sclerosis, an autoimmune disorder.

Oral cladribine is indicated for the treatment of relapsing forms of multiple sclerosis (MS), including relapsing-remitting disease and active secondary progressive disease, in adults.

Indicated for treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease. Use generally...